Author Archive

HHS Releases Vector-borne Disease National Strategy

https://www.lymedisease.org/hhs-vector-borne-disease-strategy/

HHS releases vector-borne disease national strategy

The U.S. Department of Health and Human Services has released the National Public Health Strategy to Prevent and Control Vector-Borne Diseases in People (VBD National Strategy).

As directed by the 2019 Kay Hagan Tick Act—named after the U.S. Senator who died due to complications from a tickborne illness—HHS led a four-year process with civilian agencies and defense departments to deliver this strategy.

Co-led by the HHS Office of the Assistant Secretary for Health and the Centers for Disease Control and Prevention, the strategy identifies and describes federal priorities to detect, prevent, respond to, and control diseases and conditions caused by vectors in the United States.

This VBD National Strategy represents the largest formal federal coordination effort focused on vector-borne disease prevention and control with contributions by over 50 representatives across 17 federal agencies. This collaborative effort will help

  • Address the significant public health challenges related to vector-borne diseases;
  • Incorporate a One Health approach to enhance coordination and communication across human, animal, and environmental areas; and
  • Reverse the upward trends in illness, suffering, and death.

Growing Problem of Vector-Borne Diseases

Vectors—biting insects and arachnids like mosquitoes, ticks, fleas, and lice—can spread germs that make people sick. These diseases are major causes of death and illness worldwide, and they increasingly threaten the health and well-being of people in the United States.

Diseases and conditions spread by vectors include Lyme disease, Zika virus, West Nile virus, dengue, malaria, plague, Rocky Mountain spotted fever, and alpha-gal syndrome.

According to CDC, reported cases of these diseases doubled over the last two decades. Due to shifting land use patterns, global travel and trade, and a changing climate, the threat of existing and emerging vector-borne diseases continues to grow.

As geographic ranges of vectors expand, the number of pathogens spread by vectors continues to climb—yet only one vaccine is available to protect people against almost 20 domestic threats.

Goals of the Vector-Borne Disease National Strategy

The rising public health threat of vector-borne diseases requires a comprehensive and sustained national effort to protect people. In 2020, the U.S. government published a framework responding to this need, titled A National Public Health Framework for the Prevention and Control of Vector-Borne Diseases in Humans (Framework). A consortium expanded the Framework into this comprehensive strategy.

As stipulated in the Kay Hagan Tick Act, HHS and CDC consulted the Tick-Borne Disease Working Group while developing the interagency strategy. The strategy incorporates recommendations from the now sunset Working Group.

In addition to identifying challenges and opportunities to enhance the prevention and control of vector-borne diseases, the strategy lays out an ambitious national public health approach to develop diagnostics, drugs, and treatments for coexisting conditions. Although critical to public health and wellness, clinical and healthcare services, access to care, legal protections, and reimbursement or payment for clinical services are outside the scope of this strategy.

Implementing the VBD National Strategy

The federal government envisions a nation where vector-borne diseases no longer threaten the health and well-being of people. Agencies and departments are proactively working to protect people from illness, suffering, and death due to vector-borne diseases by

  • Better understanding when, where, and how people are exposed to and get sick or die;
  • Developing, evaluating, and improving tools, methods, and guidance to diagnose diseases and their pathogens;
  • Developing, evaluating, and improving tools, methods, and guidance to prevent and control disease;
  • Developing and assessing drugs and treatment strategies; and
  • Disseminating and implementing public health tools, programs, and collaborations to prevent, detect, diagnose, and respond to threats.

Federal Government to Develop New Approaches to the Threat

Vector-borne diseases are a global threat, with national security, economic, and health implications for the United States. As the federal government continues to proactively strengthen its response to this threat, HHS and CDC plan to develop future iterations of the VBD National Strategy with opportunities for public engagement.

Read the VBD National Strategy.

SOURCE: US Department of Health and Human Services

______________

**Comment**

It’s quite easy to see where this is going.

  1. They emphasize there’s only 1 vaccine. Vaccines are the only thing these people care about because they are big business and quite lucrative.
  2. Despite more and more experts defying the climate narrative, and proof that the entire paradigm is corrupt, and being used for a much bigger agenda, it is mentioned here because it too is big business and quite lucrative.
  3. While the article mentions diagnostics, drugs, and treatments for coexisting conditions – they won’t lift a finger regarding Lyme/MSIDS, unless it’s a vaccine.  No money in these other things.
  4. The buzz word of the day – ‘One Health’ has been hijacked by the corrupt WHO as an ultimate power grab, which would give them unlimited control over humans, animals, and the environment.
  5. Similarly to the completely unobtainable goal of a ZERO COVID policy, the federal government’s vision of a nation where vector-borne diseases no longer threaten the health and well-being of people is seriously a joke.
  6. The mention that vector borne diseases are a national security threat is code for: we are going to keep working on vector bioweapons.
Again, the only thing the HHS is going to release is a lot of hot air.

It is not going to do ONE thing to help the plight of Lyme/MSIDS patients. It will gladly spend even more of our tax-dollars to do yet more worthless research showing the same things they’ve been showing for 40 years.

Category:

Activism, Lyme, mosquitoes, Ticks, Transmission, Viruses

Peripheral Neuropathy Evaluation & Repair in Lyme Disease

https://www.treatlyme.net/guide/neuropathy-repair-heal-that-tingling-numbness-pain

Updated: 4/24/2023

Neuropathy in Lyme Disease

In chronic Lyme disease it is common to have nerve injury in locations outside of the brain and spinal cord – also called peripheral neuropathy. Common symptoms of peripheral neuropathy include:

  • numbness,
  • burning sensations,
  • and/or sharp, stabbing or electric feelings.

In this article Marty Ross MD reviews:

  • laboratory evaluation of neuropathy in chronic Lyme disease and a functional medicine approach to remove nerve insults and to repair nerve injury.

Neuropathy Laboratory Evaluation

A basic laboratory evaluation of neuropathy may include:

  • Vitamin B6 (too much Vitamin B6 causes neuropathy)
  • Vitamin B12 (low Vitamin B12 causes neuropathy)
  • Vt D3 (levels around 40 ng/ml to 80ng/ml support healthy nerve function)
  • CBC
  • CMP (evaluation of kidney and liver function)
  • TSH, Free T3, and Free T4 (evaluate for low or high thyroid function)
  • TTG-IgA & EMA (for possible celiac disease)
  • heavy metal urine testing (see the end of the article for when to do this)

(See link for video and article)

_______________

For more:

Neuropathy Laboratory Evaluation

A basic laboratory evaluation of neuropathy may include:

  • Vitamin B6 (too much Vitamin B6 causes neuropathy)
  • Vitamin B12 (low Vitamin B12 causes neuropathy)
  • Vt D3 (levels around 40 ng/ml to 80ng/ml support healthy nerve function)
  • CBC
  • CMP (evaluation of kidney and liver function)
  • TSH, Free T3, and Free T4 (evaluate for low or high thyroid function)
  • TTG-IgA & EMA (for possible celiac disease)
  • heavy metal urine testing (see the end of the article for when to do this)

Functional Medicine Neuropathy Repair

Steps to repair nerve injury include:

removing the nerve insults

  • correcting abnormal labs including thyroid, Vitamin D, Vitamin B6, and Vitamin B12
  • stopping RX meds that may cause neuropathy
  • treating infections
  • correcting mold toxicity

repairing the nerve damage

  • repairing nerve cell and mitochondria power plant membranes,
  • increasing the master cell repair antioxidant glutathione,
  • increasing the nutrient Coenzyme Q10 (CoQ10)
  • taking acetyl-l-carnitine if you do not eat red meat,
  • decreasing inflammation, and
  • using the peptide BPC-157.

Category:

Lyme, Supplements, Testing

MHRA Admits Their Circular Reasoning. Flu Vaccine 42% Effective & RSV Vaccine Linked to GBS

https://expose-news.com/2024/03/12/mhra-admits-using-circular-reasoning/

MHRA admits using circular reasoning in claiming huge number of covid vaccine injuries reported are due to “high public awareness”

BY RHODA WILSON ON 

The UK Medicines and Healthcare products Regulatory Agency (“MHRA”) has acknowledged that it used circular reasoning and lacks documentation to support its explanation why there is a high number of Yellow Card reports related to covid injections. The agency asserted that the increase in reports is due to heightened public awareness, resulting in more people submitting reports than usual.  (See link for article)

________________

**Comment**

The UK’s MHRA Yellow Card scheme is similar to the  U.S. VAERS system where people can voluntarily report any suspected adverse reactions to vaccines.  Similarly to the staggering amount of adverse reactions and death being reported to VAERS after the COVID gene therapy injections, there is also an unprecedented uptick in Yellow Card reports.  Both have an abysmal capture rate.

But rather than simply admit the obvious, ‘the powers that be’ continue the #ABV narrative (anything but the ‘vaccine’) which is blaming heightened public awareness for the surge in reports despite ZERO data to support its claim.

https://thevaccinereaction.org/2024/03/influenza-vaccines-only-42-percent-effective-in-adults-this-year/

Influenza Vaccines Only 42 Percent Effective in Adults This Year

by Marco Cáceres

Published 

Article Excerpts:

The influenza vaccines currently being administered in the United States are estimated by the U.S. Centers for Disease Control and Prevention (CDC) to be 42 percent effective in adults. This is an interim estimate for the 2023-2024 “flu season” published in the agency’s Morbidity and Mortality Weekly Report (MMWR) on Feb. 29, 2024.1 2 3

By “effective,” the CDC is referring to reducing the risk of influenza-related hospitalizations or “medically attended influenza virus infection, not actually preventing influenza infections—notably influenza A (H1N1) and B (Victoria lineage).1

Most influenza-like-illness (ILI) which occurs during the “flu season” is not actually caused by  type A or type B influenza. Studies show that less than 25 percent of suspected ILI cases turn out to be influenza after lab testing. There are many other respiratory infections that look like influenza but are caused by other types of viruses and bacteria.2.4

There are nine influenza vaccines that are licensed by the U.S. Food and Drug Administration (FDA) for distribution during the 2023-2024 flu season, each of which contains at least one ingredient that is a potential allergen.

  • Alfuria contains the mercury-based preservative thimerosal (multiple-dose vials), egg protein, neomycin and polymyxin.
  • Fluad contains egg protein, kanamycin, neomycin and polysorbate 80.
  • Fluarix contains egg protein, gentamicin and polysorbate 80.
  • Flublok contains polysorbate 20.
  • Flucelvax contains thimerosal (multiple-dose vials) and polysorbate 80.
  • FluLaval contains egg protein and polysorbate 80.
  • FluMist contains egg protein, gentamicin, pork gelatin and monosodium glutamate (MSG).
  • Fluzone contains egg protein.
  • Fluzone High-Dose contains thimerosal (multiple-dose vials) and egg protein.9

https://thevaccinereaction.org/2024/03/rsv-vaccines-for-senior-adults-linked-to-guillain-barre-syndrome/

RSV Vaccines for Senior Adults Linked to Guillain-Barré Syndrome

by Rishma Parpia

Published 

Excerpts:

On Feb. 29, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) presented a preliminary analysis that showed that 23 adults over the age of 65 who received a respiratory syncytial virus (RSV) vaccine developed Guillain-Barré syndrome (GBS).1 When a person develops GBS, including after an infection or vaccination, the body attacks the peripheral nerves. GBS symptoms begin with muscle weakness and numbness or tingling in different parts of the body and recovery can be complete or paralysis of one or more limbs can occur, including full body paralysis, which can lead to death.2

The CDC’s analysis evaluated preliminary rates of GBS following one dose of either GSK plc’s RSVPreF3+AS01 (AREXVY) vaccine or Pfizer, Inc.’s RSVPreF (ABRYSVO) vaccine and compared it to the rates of GBS in an historical control group.

Data from the U.S. Food and Drug Administration (FDA) also illustrated a higher- than-expected number of GBS cases being reported in RSV vaccine recipients. Tom Shimabukuro, MD, director of the Immunization Safety Office at the CDC said:

Taken together, these data suggest a potential increased risk [of GBS after RSV vaccinations].6

 For more:

Category:

Activism, vaccines

CHD Sues AT&T on Behalf of Woman Who Alleges Cell Tower Caused 51 Strokes & NJ Residents Win Right To Deny Verizon’s Application To Build Nine 5G Towers on Boardwalk

https://childrenshealthdefense.org/defender/chd-lawsuit-cell-tower-wireless-radiation-51-strokes-

CHD Sues AT&T on Behalf of Woman Who Alleges Cell Tower Caused 51 Strokes

The lawsuit, filed on March 11, is Children’s Health Defense’s second case that strategically uses the Americans with Disabilities Act on behalf of those who get sick from wireless radiation.

This article was originally published by The Defender — Children’s Health Defense’s News & Views Website.

A Minnesota woman alleging the radiofrequency radiation emitted by a cell tower near her home triggered 51 strokes on Monday sued AT&T and other companies involved in the operation of the tower.

Children’s Health Defense (CHD), which is funding the lawsuit, filed the complaint on behalf of Marcia Haller, who previously told The Defender she became disabled shortly after the cell tower was “upgraded” in 2019.

In addition to suffering dozens of strokes since then, she’s suffered vision and hearing loss, headaches, sleep disruption, chronic fatigue and cognitive impairment. She also experiences ongoing issues with balance, orientation and mobility.

The lawsuit, filed in the U.S. District Court for the District of Minnesota (Duluth), alleges the companies operating the tower must provide Haller with a “reasonable accommodation” and/or modify their “policies, practices or procedures” to comply with federal disability law.

In addition to AT&T, defendants in the suit include T-Mobile and American Tower.

This is CHD’s second lawsuit leveraging the Americans with Disabilities Act (ADA) on behalf of individuals suffering from radiofrequency (RF) radiation exposure.

“CHD is excited to file the second complaint in this strategic line of cases,” Miriam Eckenfels-Garcia, director of CHD’s Electromagnetic Radiation (EMR) & Wireless program, said.

“We hope we will be able to help Marcia get relief, while at the same time, drive the conversation around electromagnetic sensitivity, RF radiation, and the lack of recourse for those harmed by cell towers forward,” Eckenfels-Garcia said.

The case draws attention to the need for better federal regulation of RF radiation and outlines the scientific evidence that debunks the “RF radiation is safe” narrative, according to Eckenfels-Garcia.

According to the lawsuit, Haller’s physician said that Haller’s symptoms — including “life-threatening embolic strokes” — occur when she is exposed to high levels of RF radiation or pulsated RF radiation, such as 5G.

“Her physical impairments already substantially limit major life activities … and RF exposure triggers and/or exacerbates her symptoms and condition,” the complaint said.

The companies could “easily and with minimal cost” take action to end Haller’s symptoms, “but they have refused to do so” — despite receiving a letter about her symptoms.

The suit asks the court to declare that the ADA applies to Haller’s situation. This would mean that the companies would be liable for discriminating against Haller because they failed to accommodate her disability.

It also seeks injunctive relief, meaning that it wants the court to order the companies to “end the discrimination” by either relocating their tower or reducing the amount of RF radiation it emits.

Haller is requesting a jury trial and compensation for attorney fees and costs.

Cell tower was likely ‘upgraded’ for 5G

Marcia and her husband, Jay, believe the cell tower was upgraded in 2019 for deploying 5G. “They [the companies] won’t admit to what they did,” Marcia told The Defender. “They say they don’t have to tell us.”

Marcia at the time was in her third semester of nursing school and worked as a certified nursing assistant at a hospital.

On the weekend after the upgrade, Marcia was at home and began feeling dizzy and as if something “just didn’t feel right.”

She called Jay, who runs a trucking business, telling him, “Something’s wrong in my head … I don’t know how to explain it. I just feel like crap.” But she told Jay she didn’t need him to come home. “I’ll be fine,” she said.

The physical sensation was “awful,” Marcia said. In addition to dizziness, she had headaches and nausea. “I couldn’t pick my head up off the pillow without the room spinning and feeling very sick.”

‘We think you’re having a stroke’

The symptoms continued. On Monday, she went to urgent care and was diagnosed with vertigo.

She returned home. A few days later, she had blind spots in her vision and tingling in her arm with “almost a numb feeling.”

Marcia called the on-call nurse center. They told her, “You need to come down to the emergency room. We think you’re having a stroke.”

An MRI of Marcia’s brain showed numerous damaged areas called lesions. She was admitted to the hospital on Oct. 10, 2019, and diagnosed with strokes, vision loss and balance difficulties.

After three days in the hospital, the strokes stopped happening — meaning MRIs of her brain showed no new lesions — and Marcia returned home.

But before the end of the month, Marcia “started feeling the same thing again” and went back to the emergency room.

Jay recalled, “We were home — the kid [Marcia and Jay’s son] and I — and she was cooking dinner … She turned around and her face had actually drooped on this one. It was like ‘uh-oh.’”

Marcia went back to the hospital, where she was diagnosed with more brain lesions. A neurologist told Marcia the MRI scan of her brain looked like a “starry night” because of how many white spots, or lesions, appeared.

The doctors still did not know what was causing them, she said.

Multiple trips to the hospital

Over the following weeks, Marcia went “back and forth a few times” between her home and her local hospital.

After a night or two at the hospital, she would begin feeling better. But after returning home, her symptoms reemerged and she’d have to return to the hospital. “Each time, more strokes,” she said.

According to Jay, “A week or 10 days later, there’d be seven or 10 new ones [lesions appearing in the MRI scans]. This was going on for about a month. I think we rounded up to about 51 complete strokes.”

Still, her local hospital doctors couldn’t explain why this was happening.

In November 2019, Marcia saw doctors at the Mayo Clinic who began treating her symptoms with plasmapheresis to put new plasma in her blood, steroids and a medication called CellCept.

But after a second round of treatment, Marcia had more strokes — including one that temporarily impaired her hearing — and she continued to experience extreme fatigue.

‘That’s when we started piecing things together’

During one of Marcia’s stays at the Mayo Clinic, Jay “just woke up” with a strong sense that the cell tower radiation was causing Marcia’s symptoms. “Then he started doing research and that’s when we started piecing things together,” Marcia explained.

Based on what Jay was discovering, he and Marcia decided to try living elsewhere.

On March 3, 2020, they and their son moved into Marcia’s parents’ house a mile further away from the tower. Marcia “got a lot better,” she said. The strokes stopped.

By June, she was talking about returning to school, Jay said. “We’d go fishing every night and she just had a lot more energy.”

Around the same time, Marcia’s doctors at the Mayo Clinic had Marcia taking pill chemotherapy. “So they’re patting themselves on the back for the chemo,” Jay said, “I think it was moving that made it stop.”

But in October 2020, Marcia’s parents returned so Jay, Marcia and their son moved back to their house close to the tower.

In just a week, Marcia started experiencing the same symptoms again.

‘Living through this has stolen a piece of us we will never get back’

Jay and Marcia became more convinced that the RF radiation from the tower was making Marcia sick.

They think living so close to the tower may have been a factor in Jay’s development of rheumatoid arthritis. Their son, too, has had negative health episodes — including a major blood clot in his left arm — that Marcia and Jay suspect may have been linked to the radiation.

Jay said he wouldn’t call it a coincidence that “all members of our household have been struck with rare illnesses and permanent health problems that will impair us for the rest of our lives.”

“Living through this has stolen a piece of us we will never get back,” he added.

Oct. 16, 2020, they hired Frank DiCristina — a certified building biologist and certified EMR specialist — to measure the wireless radiation levels throughout their home.

DiCristina’s report showed peaks of up to 18 milliwatts per squared meter (mW/m2) — which is 18 times higher than what the Standard of Building Biology considers the “extreme limit,” noted DiCristina in the report.

In late October 2020, Jay constructed a Faraday cage — an enclosure with metal lining that blocks out all RF radiation — to give Marcia a place of relief from the radiation.

Having a space free of RF radiation has made a big difference in Marcia’s well-being, but she said it’s not fun having to go into a small enclosed space to feel OK.

She and Jay call the Faraday cage “the penalty box.” It’s a tiny room with no power and no windows — just a “complete black box with two beds,” Marcia said.

She and Jay sleep there, with their 18-year-old son spending the night away from home as often as possible. “I would be nervous to sleep in my house because I don’t want to get sick again,” Marcia said.

Marcia also now wears a silver-lined baseball cap designed to block RF radiation when in her home. With these measures, she slowly was able to complete her nursing program and return to work.

However, she still experiences symptoms on her property when outside the Faraday cage. “Simple things like enjoying the fire pit, gardening and just relaxing on the deck are now basically a memory,” Marcia said.

This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.

________________

https://childrenshealthdefense.org/defender/new-jersey-residents-opposing-5g-towers-intervene-verizon-lawsuit/

New Jersey Residents Opposing 5G Towers Win Right to Intervene in Verizon Lawsuit

A federal judge last week gave residents of Belmar, New Jersey, the green light to intervene in a lawsuit brought by Verizon against Monmouth County after county officials denied the telecom giant’s applications to build nine 5G towers on a stretch of boardwalk located in the county.

Residents of Belmar, New Jersey, won the right to intervene in a lawsuit Verizon brought against Monmouth County officials for allegedly illegally denying the telecom giant’s applications to build nine 5G towers on a stretch of boardwalk located in the county.

U.S. Magistrate Judge J. Brendan Day last week ruled that a local activist group, Belmar Against 5G Towers, and seven individuals who claim Verizon’s proposed wireless facilities could harm their local environment and property values may join the suit. (See link for article)

Important quote:

“The proposed 5G towers impact their health, the environment they live in, their property values and the aesthetics of their neighborhood, so it is important that they can advocate for their interests in this litigation,” Eckenfels-Garcia told The Defender.

________________

**Comment**

Expect to see more of this.

How many are experiencing symptoms but are not connecting the dots to EMF?

Once again, technology is being widely rolled out despite lack of safety. Please also note the supreme power the utility companies have been given and their complete lack of transparency and their disregard for human health.  This is the new norm, unfortunately.  I have discovered this personally when attempting to “opt out” of Smart Meters.  They simply don’t care.

People shouldn’t have to sue the utility company to be free of radiation emitting technology but here we are.  People also shouldn’t have to spend thousands of dollars to hire a company to expose and ameliorate this radiation as well, yet here we are.

Yes, a person could move, but before long there won’t be anywhere on planet earth to move to escape this damaging technology.  And that is, after all, the whole reason for it.

For more:

Category:

Activism, Cancer

Lyme-Induced Cardiac Problems Persist Despite Antibiotic Treatment

https://danielcameronmd.com/lyme-cardiac-antibiotic-treatment/

LYME-INDUCED CARDIAC PROBLEMS PERSIST DESPITE ANTIBIOTIC TREATMENT

lyme-cardiac

In their article, “An Unusual Presentation of Lyme Carditis and Adenosine-Sensitive Atrioventricular Block,” Alexandre and colleagues present the case of a 20-year-old female with Lyme disease and cardiac manifestations, who continued to experience cardiac problems despite 4 weeks of antibiotic treatment. [1]

By 

The young woman was admitted to the emergency department with acute pleuritic chest pain and shortness of breath. (Pleuritic chest pain is characterized by sudden and intense sharp, stabbing, or burning pain in the chest when inhaling and exhaling.)

The woman exhibited only mild tachycardia (100/min). However, “Considering the suspicion of acute myocarditis, the patient was admitted to an intensive cardiac care unit,” the authors state.

During hospitalization, cardiac monitoring revealed several asymptomatic episodes of paroxysmal AV block, including second-degree Mobitz I AV block, second degree AV block, and high-grade AV block.

Although there was no evidence of tick exposure or skin lesions, clinicians ordered testing for Lyme disease, which was positive by Western blot. “… an IgM Western-Blot test was performed, confirming positivity and recent Borrelia spp. infection.”

The patient was diagnosed with Lyme disease with cardiac manifestations of high-grade AV block. She was treated with a 4-week course of IV ceftriaxone, which led to a complete resolution of chest pain and shortness of breath.

However, the AV conduction disturbance continued after 4 weeks of antibiotic treatment. And subsequently, the woman was given an alternative diagnosis of extrinsic idiopathic paroxysmal AV block (“adenosine-sensitive AV block”).

This could be an extremely rare course of Lyme carditis, or the patient may have had asymptomatic AV conduction problems that surfaced when she developed Lyme disease, according to the authors.

“The patient was started on theophylline 400 mg twice daily, and after one week of treatment, the Holter monitoring demonstrated a significant reduction in AV conduction disturbances,” the authors state.

At her 18-month follow-up appointment, the woman continued to have fewer AV conduction disturbances, no cardiac complaints, and no need for a permanent pacemaker.

Authors conclude:

“This case illustrates a challenging scenario of [Lyme carditis] with high grade AV block, which persisted after appropriate antibiotic treatment and had key features supporting the diagnosis of extrinsic idiopathic paroxysmal AV block (‘adenosine sensitive AV block’).

References:
  1. Alexandre A, Ribeiro D, Sousa MJ, Reis H, Silveira J, Torres S. An Unusual Presentation of Lyme Carditis and Adenosine-Sensitive Atrioventricular Block. Arq Bras Cardiol. 2024 Jan;121(1):e20230228. Portuguese, English. doi: 10.36660/abc.20230228. PMID: 38324857.

For more:

Category:

Heart Issues, Lyme, research, Testing, Treatment, Uncategorized